The University of Southampton
University of Southampton Institutional Repository

P166 utility of lung clearance index (LCI2.5) as an outcome measure in cystic fibrosis clinical trials – perspectives of people with cystic fibrosis and LCI2.5 operators

P166 utility of lung clearance index (LCI2.5) as an outcome measure in cystic fibrosis clinical trials – perspectives of people with cystic fibrosis and LCI2.5 operators
P166 utility of lung clearance index (LCI2.5) as an outcome measure in cystic fibrosis clinical trials – perspectives of people with cystic fibrosis and LCI2.5 operators
Objectives: we explored the perspectives of people with cystic fibrosis (pwCF) and multiple breath washout (MBW) operators regarding the use of LCI2.5 in the ‘Exercise as an Airway Clearance Technique in CF (ExACT-CF)’ trial.

Methods: LCI2.5 was measured at baseline and 28-days by nitrogen-multiple breathwashout (N2-MBW; Exhalyzer-D, EcoMedics, Switzerland), with training and over-reading support provided by the ECFS-CTN LCI Core Facility and the UK CF Trust Clinical Trials Accelerator Platform (London). A subsample of participants, parents and trial staff also undertook semi-structured interviews regarding their trial experiences, including outcome measures. Participants were also invited to complete a short bespoke questionnaire focused on ease and comfort of performing N2-MBW, perceptions regarding time to do the test, and their willingness to perform N2-MBW in the future; using a Likert (1–5) scale. Free-text comments were also analysed. Qualitative interview transcripts were thematically analysed using a Framework Approach and any outcomes relating to N2-MBW collated.

Results: of 50 participants recruited into the trial, MBWwas performed in 49. Of the 15 questionnaire respondents (6 paediatric, 9 adults), 86.7% ranked the test as easy or very easy to perform, 93.3% ranked it comfortable or very comfortable, and 86.7% would be willing to perform the test again. Further qualitative insight into the use of LCI2.5 will be presented at the conference.

Discussion: questionnaire responses and qualitative data frompwCF in the ExACT-CF study suggest that N2-MBW is easy to perform, comfortable to do, and is a test that pwCF across a range of ages and disease severities would be willing to do again. Study participants did not perceive an excessive time burden with N2-MBW and qualitative and questionnaire information supports the ease of performing the test; however the low sample size is acknowledged.

Funding: NIHR Research for Patient Benefit grant (NIHR203185).
1569-1993
S106-S107
Kilarski, E.
46e8e38d-e569-4952-bc35-ec1d474afa06
Taylor, E.
4cda4bb0-a62a-4bb0-8da7-95e579333f43
Abkir, M.
264f4691-8033-4fc6-811f-f76f8dabb592
Saunders, C.
d911df0e-f0a8-4f1a-9235-6665bea6fd5a
Cunningham, S.
b3254953-7c17-4039-a3c4-41dea6e784cf
Lewis, S.
fff0ee15-3e6a-4778-be27-665eb8118fdb
Neilson, A.
02f0b387-f713-4149-b032-4c06de178cb9
Ensor, H.
fef65ebc-969d-43bd-ac7e-0d048d893d0b
Miller, D.
e2f8acf7-f3ab-4c57-93d2-8e92acfa8e07
Bowen, D.
f16a9ae3-04e3-434d-90e7-c844f5e33b2b
Lacey, E.
01ee8216-a309-4095-9c5d-2623ad977040
Vogiatzis, I.
425495ee-5031-41d6-8869-6964281f03c9
Allen, L.
92f381de-9f39-48af-afbc-c0b3bb7d18e4
Soilemezi, D.
430bc30b-2e93-4ed7-b654-4fb602e2d025
Saynor, Z.
a4357c7d-db59-4fa5-b24f-58d2f7e74e39
Urquhart, D.
0ac2e542-e98a-47ad-afb7-543298f8e0fa
Kilarski, E.
46e8e38d-e569-4952-bc35-ec1d474afa06
Taylor, E.
4cda4bb0-a62a-4bb0-8da7-95e579333f43
Abkir, M.
264f4691-8033-4fc6-811f-f76f8dabb592
Saunders, C.
d911df0e-f0a8-4f1a-9235-6665bea6fd5a
Cunningham, S.
b3254953-7c17-4039-a3c4-41dea6e784cf
Lewis, S.
fff0ee15-3e6a-4778-be27-665eb8118fdb
Neilson, A.
02f0b387-f713-4149-b032-4c06de178cb9
Ensor, H.
fef65ebc-969d-43bd-ac7e-0d048d893d0b
Miller, D.
e2f8acf7-f3ab-4c57-93d2-8e92acfa8e07
Bowen, D.
f16a9ae3-04e3-434d-90e7-c844f5e33b2b
Lacey, E.
01ee8216-a309-4095-9c5d-2623ad977040
Vogiatzis, I.
425495ee-5031-41d6-8869-6964281f03c9
Allen, L.
92f381de-9f39-48af-afbc-c0b3bb7d18e4
Soilemezi, D.
430bc30b-2e93-4ed7-b654-4fb602e2d025
Saynor, Z.
a4357c7d-db59-4fa5-b24f-58d2f7e74e39
Urquhart, D.
0ac2e542-e98a-47ad-afb7-543298f8e0fa

Kilarski, E., Taylor, E., Abkir, M., Saunders, C., Cunningham, S., Lewis, S., Neilson, A., Ensor, H., Miller, D., Bowen, D., Lacey, E., Vogiatzis, I., Allen, L., Soilemezi, D., Saynor, Z. and Urquhart, D. (2024) P166 utility of lung clearance index (LCI2.5) as an outcome measure in cystic fibrosis clinical trials – perspectives of people with cystic fibrosis and LCI2.5 operators. Journal of Cystic Fibrosis, 23 (Suppl. 1), S106-S107. (doi:10.1016/S1569-1993(24)00428-4).

Record type: Article

Abstract

Objectives: we explored the perspectives of people with cystic fibrosis (pwCF) and multiple breath washout (MBW) operators regarding the use of LCI2.5 in the ‘Exercise as an Airway Clearance Technique in CF (ExACT-CF)’ trial.

Methods: LCI2.5 was measured at baseline and 28-days by nitrogen-multiple breathwashout (N2-MBW; Exhalyzer-D, EcoMedics, Switzerland), with training and over-reading support provided by the ECFS-CTN LCI Core Facility and the UK CF Trust Clinical Trials Accelerator Platform (London). A subsample of participants, parents and trial staff also undertook semi-structured interviews regarding their trial experiences, including outcome measures. Participants were also invited to complete a short bespoke questionnaire focused on ease and comfort of performing N2-MBW, perceptions regarding time to do the test, and their willingness to perform N2-MBW in the future; using a Likert (1–5) scale. Free-text comments were also analysed. Qualitative interview transcripts were thematically analysed using a Framework Approach and any outcomes relating to N2-MBW collated.

Results: of 50 participants recruited into the trial, MBWwas performed in 49. Of the 15 questionnaire respondents (6 paediatric, 9 adults), 86.7% ranked the test as easy or very easy to perform, 93.3% ranked it comfortable or very comfortable, and 86.7% would be willing to perform the test again. Further qualitative insight into the use of LCI2.5 will be presented at the conference.

Discussion: questionnaire responses and qualitative data frompwCF in the ExACT-CF study suggest that N2-MBW is easy to perform, comfortable to do, and is a test that pwCF across a range of ages and disease severities would be willing to do again. Study participants did not perceive an excessive time burden with N2-MBW and qualitative and questionnaire information supports the ease of performing the test; however the low sample size is acknowledged.

Funding: NIHR Research for Patient Benefit grant (NIHR203185).

This record has no associated files available for download.

More information

e-pub ahead of print date: 7 June 2024
Published date: 7 June 2024

Identifiers

Local EPrints ID: 493885
URI: http://eprints.soton.ac.uk/id/eprint/493885
ISSN: 1569-1993
PURE UUID: 5f532cac-3b83-4e71-9155-88f12b4c40fe
ORCID for Z. Saynor: ORCID iD orcid.org/0000-0003-0674-8477

Catalogue record

Date deposited: 16 Sep 2024 16:53
Last modified: 17 Sep 2024 02:09

Export record

Altmetrics

Contributors

Author: E. Kilarski
Author: E. Taylor
Author: M. Abkir
Author: C. Saunders
Author: S. Cunningham
Author: S. Lewis
Author: A. Neilson
Author: H. Ensor
Author: D. Miller
Author: D. Bowen
Author: E. Lacey
Author: I. Vogiatzis
Author: L. Allen
Author: D. Soilemezi
Author: Z. Saynor ORCID iD
Author: D. Urquhart

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×